logo

For the Inventor, By the Inventor

Lawrenceville, NJ, United States of America

Muthoni G Kamau

This inventor holds 14 USPTO granted patents and 1 published patent application and 7 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muthoni G Kamau. Retrieved from https://idiyas.com/inventor/muthoni-g-kamau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.5

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:

goldMedal14 out of 3,742 
 
Bristol-Myers Squibb Compnay
 patents

Years Active: 2010-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 12012374 - Agonists of ROR GAMMAt (2024-06-18),
2. 11667663 - Cyclic dinucleotides as anticancer agents (2023-06-06),
3. 11660311 - Cyclic dinucleotides as anticancer agents (2023-05-30),
4. 11339185 - Cyclic dinucleotides as anticancer agents (2022-05-24),
5. 10744150 - Cyclic dinucleotides as anticancer agents (2020-08-18),
6. 10519187 - Cyclic dinucleotides as anticancer agents (2019-12-31),
7. 10196387 - Carbazole compounds useful as bromodomain inhibitors (2019-02-05),
8. 10053454 - Carbazole compounds useful as bromodomain inhibitors (2018-08-21),
9. 9708316 - TGFβR antagonists (2017-07-18),
10. 8642576 - Heterocyclic CETP inhibitors (2014-02-04),
11. 8445676 - Pyrrolotriazine kinase inhibitors (2013-05-21),
12. 8304403 - Heterocyclic CETP inhibitors (2012-11-06),
13. 7888376 - Heterocyclic CETP inhibitors (2011-02-15),
14. 7790770 - Heterocyclic CETP inhibitors (2010-09-07),

Title: Inventor Spotlight: Muthoni G. Kamau

Introduction

Muthoni G. Kamau is a prominent inventor based in Lawrenceville, NJ, known for her significant contributions to pharmaceutical research and innovation. With a remarkable portfolio of 14 patents, she has made strides in the development of compounds aimed at treating various medical disorders.

Latest Patents

Among her latest patents, Muthoni has developed an invention titled "Agonists of ROR GAMMAt." This innovative work is directed to novel compounds that have potential therapeutic applications. The invention encompasses pharmaceutically acceptable compositions and methods for utilizing these compounds in treating various disorders. Another notable patent, "Cyclic dinucleotides as anticancer agents," focuses on a unique formula aimed at combating cancer through similarly defined compounds and their compositions.

Career Highlights

Muthoni G. Kamau currently contributes her talents to Bristol-Myers Squibb Company, a leading global biopharmaceutical firm. Her role within the company has enabled her to leverage her innovative insights in drug development, furthering research that can lead to groundbreaking treatments.

Collaborations

Throughout her career, Muthoni has collaborated with talented colleagues, including Lalgudi S. Harikrishnan and Dharmpal S. Dodd. These collaborations enhance the collective expertise available for addressing complex challenges in medical treatments and patents.

Conclusion

Muthoni G. Kamau exemplifies the spirit of innovation within the pharmaceutical industry. Her work not only highlights her ingenuity as an inventor but also demonstrates the potential impact of her patents on healthcare. With continued research and collaboration, Muthoni is set to influence the future of medicine through her groundbreaking inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…